HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Olga Genin Selected Research

Dysferlinopathy

1/2020Early pathological signs in young dysf-/- mice are improved by halofuginone.
3/2017Elevated Expression of Moesin in Muscular Dystrophies.
3/2013The involvement of collagen triple helix repeat containing 1 in muscular dystrophies.
1/2013Inhibition of muscle fibrosis and improvement of muscle histopathology in dysferlin knock-out mice treated with halofuginone.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Olga Genin Research Topics

Disease

12Fibrosis (Cirrhosis)
06/2021 - 11/2008
6Muscular Dystrophies (Muscular Dystrophy)
06/2021 - 11/2008
5Neoplasms (Cancer)
01/2012 - 02/2007
4Dysferlinopathy
01/2020 - 01/2013
3Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
06/2021 - 09/2015
3Hypoxia (Hypoxemia)
08/2015 - 09/2008
1Hypertrophy
01/2020
1Epilepsy (Aura)
01/2019
1Liver Cirrhosis (Hepatic Cirrhosis)
08/2015
1Alcoholic Fatty Liver
08/2015
1Disease Progression
03/2013
1Inflammation (Inflammations)
01/2013
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2012
1Vitamin D Deficiency
07/2011
1Osteochondrodysplasias (Spondyloepiphyseal Dysplasia)
07/2011
1Rickets (Rachitis)
07/2011
1Renal Cell Carcinoma (Grawitz Tumor)
09/2008
1Necrosis
02/2007
1Prostatic Neoplasms (Prostate Cancer)
02/2007
1Wilms Tumor (Wilm's Tumor)
02/2007

Drug/Important Bio-Agent (IBA)

14halofuginoneIBA
06/2021 - 02/2007
6CollagenIBA
03/2013 - 09/2008
3Transforming Growth Factor beta (TGF-beta)IBA
05/2009 - 09/2008
2febrifugineIBA
06/2021 - 07/2019
2Transforming Growth Factors (Transforming Growth Factor)IBA
07/2019 - 03/2013
2Collagen Type I (Type I Collagen)IBA
09/2015 - 02/2007
2CeruletideIBA
10/2010 - 05/2009
2Prolyl Hydroxylases (Prolyl Hydroxylase)IBA
10/2010 - 09/2008
2CytoglobinIBA
09/2008 - 02/2007
1Carbamazepine (Tegretol)FDA LinkGeneric
01/2019
1Anticonvulsants (Antiepileptic Drugs)IBA
01/2019
1moesinIBA
03/2017
1ezrinIBA
03/2017
1Laminin (Merosin)IBA
03/2017
1radixinIBA
03/2017
1IntegrinsIBA
03/2016
1DystrophinIBA
09/2015
1UtrophinIBA
09/2015
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
08/2015
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
08/2015
1CholesterolIBA
08/2015
1DysferlinIBA
01/2013
1Green Fluorescent ProteinsIBA
01/2012
1AntibodiesIBA
01/2012
1Collagen Type II (Type II Collagen)IBA
07/2011
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
07/2011
1ThiramFDA Link
07/2011
1Heat-Shock Proteins (Heat-Shock Protein)IBA
07/2011
1Alkaline PhosphataseIBA
07/2011
1matrigelIBA
10/2010
1JNK Mitogen-Activated Protein KinasesIBA
05/2009
1Proteins (Proteins, Gene)FDA Link
09/2008
1EnzymesIBA
09/2008
1transgelinIBA
02/2007
1Docetaxel (Taxotere)FDA Link
02/2007
1Dactinomycin (Actinomycin)FDA LinkGeneric
02/2007
1Vincristine (Oncovin)FDA LinkGeneric
02/2007

Therapy/Procedure

4Therapeutics
07/2019 - 05/2009
2Drug Therapy (Chemotherapy)
01/2012 - 02/2007